Cargando…
Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure
Acute heart failure (AHF) is the most common primary diagnosis for hospitalized heart diseases in Africa. As increased fatty acid β-oxidation (FAO) during heart failure triggers detrimental effects on the myocardium, we hypothesized that trimetazidine (TMZ) (partial FAO inhibitor) offers cardioprote...
Autores principales: | Breedt, Emilene, Lacerda, Lydia, Essop, M. Faadiel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478112/ https://www.ncbi.nlm.nih.gov/pubmed/28632748 http://dx.doi.org/10.1371/journal.pone.0179509 |
Ejemplares similares
-
Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021) -
Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?
por: Zhou, Xiang, et al.
Publicado: (2014) -
Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
por: Shu, Hongyang, et al.
Publicado: (2021) -
Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia‐reperfusion
por: Mapanga, Rudo F., et al.
Publicado: (2017) -
Effects of ivabradine hydrochloride combined with trimetazidine on myocardial fibrosis in rats with chronic heart failure
por: Ma, Dongwen, et al.
Publicado: (2019)